SFPM(SZ:002737) Zheng Quan Zhi Xing·2025-07-25 16:49Core Viewpoint - The company,葵花药业集团股份有限公司, has announced the cancellation and absorption merger of certain subsidiaries to optimize its investment holding structure and reduce costs [1][3]. Summary by Sections 1. Announcement of Cancellation and Absorption Merger - The company will cancel its wholly-owned subsidiary, 黑龙江葵花大药房有限公司, and absorb 黑龙江省葵花包装材料有限公司 and 黑龙江葵花药材基地有限公司 into 黑龙江葵花药业股份有限公司 [1][3]. - The cancellation and absorption are based on actual business needs and aim to streamline management and integrate resources effectively [1][3]. 2. Financial Overview of Subsidiaries - 黑龙江省葵花包装材料有限公司: - Total assets as of June 30, 2025: 1,233.17 million yuan - Total liabilities as of June 30, 2025: 35.50 million yuan - Net assets as of June 30, 2025: 1,197.67 million yuan - Revenue for the first half of 2025: 663.10 million yuan - Net profit for the first half of 2025: 70.96 million yuan [4]. - 黑龙江葵花药材基地有限公司: - Total assets as of June 30, 2025: 1,201.70 million yuan - Total liabilities as of June 30, 2025: 2.43 million yuan - Net assets as of June 30, 2025: 1,199.25 million yuan - Revenue for the first half of 2025: 1,027.56 million yuan - Net profit for the first half of 2025: -6.62 million yuan [4]. 3. Purpose and Impact of the Merger - The merger aims to optimize the investment holding system, shorten management chains, and achieve effective resource integration [3][5]. - The merger will not affect the company's business scope, total share capital, or registered capital, and will not significantly impact overall financial and operational performance [3][5]. 4. Legal Procedures - The cancellation and absorption merger will require compliance with relevant legal procedures, with final confirmation based on local market supervision department registration [5].